New blood test may predict lung surgery risks

NCT ID NCT07359885

Not yet recruiting Diagnosis Sponsor: University Hospital, Rouen Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aims to see if a blood test, taken before lung cancer surgery, can predict which patients will develop serious lung complications afterward. Researchers will analyze immune cells and proteins in the blood of 100 adults undergoing lung surgery. If the test works, it could help doctors take early steps to prevent complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: blood test (immune cell and protein analysis)
What this could lead to: If successful, this could lead to a simple blood test that helps doctors identify patients at high risk of lung complications after surgery, allowing for better preventive care.
What could go wrong: This is a small, early-stage study (100 participants) that has not yet started recruiting. The test is still being developed and may not prove accurate enough for routine use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POSTOPERATIVE PULMONARY COMPLICATIONS (PPCS)

Contacts and locations

Locations

Service de Anesthésie-Réanimation Médecine périopératoire CHU de Rouen

Rouen, 76100, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.